Takeda Pharmaceutical (TAK) Change in Inventory (2018 - 2026)

Takeda Pharmaceutical's Change in Inventory history runs 9 years deep, the most recent figure standing at $119.2 million for Q1 2026.

• In Q1 2026, Change in Inventory rose 464.42% year-over-year to $119.2 million; the TTM figure through Mar 2026 stood at -$414.3 million (down 77.38% YoY), while the FY2026 annual figure was -$407.2 million, down 77.35% from the prior year.
• Change in Inventory was $119.2 million for Q1 2026 at Takeda Pharmaceutical, up from -$246.7 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $139.7 million in Q4 2024 to a low of -$342.0 million in Q4 2023.
• Historically, Change in Inventory has averaged -$123.7 million across 5 years, with a median of -$90.3 million in 2025.
• The sharpest annual moves came in 2023 and 2026: Change in Inventory slumped 608.63% in 2023, then soared 464.42% in 2026.
• A 5-year view of Change in Inventory shows it stood at -$130.7 million in 2022, then slumped by 161.71% to -$342.0 million in 2023, then jumped by 140.85% to $139.7 million in 2024, then tumbled by 276.58% to -$246.7 million in 2025, then jumped by 148.34% to $119.2 million in 2026.
• The last three Change in Inventory figures came in at $119.2 million (Q1 2026), -$246.7 million (Q4 2025), and -$196.6 million (Q3 2025), per Business Quant data.